BRIEF published on 12/10/2024 at 10:51, 11 months 26 days ago Franchissement de seuil par Cyrille Tupin chez ABIONYX PHARMA Droits De Vote Franchissement De Seuil Actions ABIONYX Pharma Cyrille Tupin
BRIEF published on 12/10/2024 at 10:51, 11 months 26 days ago Threshold crossing by Cyrille Tupin at ABIONYX PHARMA Voting Rights Actions Threshold Crossing ABIONYX Pharma Cyrille Tupin
PRESS RELEASE published on 12/10/2024 at 10:46, 11 months 26 days ago Franchissement de seuil Déclaration de franchissement de seuil par M. Cyrille Tupin concernant ABIONYX PHARMA. Détention de 4,56% du capital et 6,06% des droits de vote Déclaration Droits De Vote Franchissement De Seuil ABIONYX Pharma Cyrille Tupin
BRIEF published on 11/14/2024 at 19:05, 1 year ago ABIONYX Pharma : Bilan financier du troisième trimestre 2024 Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma T3 2024
BRIEF published on 11/14/2024 at 19:05, 1 year ago ABIONYX Pharma: Third quarter 2024 financial report Biotechnology Treasury Turnover Q3 2024 ABIONYX Pharma
PRESS RELEASE published on 11/14/2024 at 19:00, 1 year ago Information financière trimestrielle / Information financière du troisième trimestre ABIONYX Pharma communique son chiffre d'affaires et sa trésorerie du 3ème trimestre 2024. Retransmission de l'AGE le 28 novembre 2024 Chiffre D'affaires Trésorerie ABIONYX Pharma 3ème Trimestre 2024 Retransmission AGE
PRESS RELEASE published on 11/14/2024 at 19:00, 1 year ago Quarterly financial reporting / Third quarter financial report ABIONYX Pharma reports Q3 2024 revenue of €3.4m and cash position of €4.1m before IRIS Pharma's CIR receipt. General Meeting on November 28, 2024, at 2.00 pm CET Cash Position General Meeting Biotech Company ABIONYX Pharma Revenue Update
BRIEF published on 10/24/2024 at 19:35, 1 year 1 month ago ABIONYX Pharma présente les résultats de l'étude RACERS ABIONYX Pharma CER-001 Brain-fog Neuro-inflammation Kidney Week
BRIEF published on 10/24/2024 at 19:35, 1 year 1 month ago ABIONYX Pharma presents the results of the RACERS study ABIONYX Pharma CER-001 Brain Fog Kidney Week Neuroinflammation
PRESS RELEASE published on 10/24/2024 at 19:30, 1 year 1 month ago Informations privilégiées / Autres communiqués ABIONYX Pharma présente les résultats cliniques de l'étude RACERS sur le brouillard cérébral et l'efficacité de CER-001 au congrès annuel 2024 de l'ASN. Nouvelles données sur la neuro-inflammation et les troubles cognitifs ASN ABIONYX Pharma CER-001 Brain-fog Étude RACERS
Published on 12/05/2025 at 23:30, 17 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 2 hours 2 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 17 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 27 minutes ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 22:15, 1 hour 31 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 35 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 49 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 5 hours 31 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 47 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 47 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 47 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 47 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 29 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
